Home Page
About Us
Journal History
Free-of-Charge Publication
Abstracting And Indexing
Copyright
Digital Archiving and Preservation Policy
Aims and Scope
Editorial Board
Instructions to Authors
Instructions to Authors
Ethical Policy
Contact Us
Archive
Author Index
Web Site of Urooncology Association
Archive
Author Index
Web Site of Urooncology Association
E-ISSN:2667-4610
Toggle navigation
Home Page
About Us
Journal History
Free-of-Charge Publication
Abstracting And Indexing
Copyright
Digital Archiving and Preservation Policy
Aims and Scope
Editorial Board
Instructions to Authors
Instructions to Authors
Ethical Policy
Contact Us
Editorial
Defining the ideal patient for active surveillance in localized prostate cancer and the impact of active surveillance studies on clinical practice
Ayhan Dirim
Hakan Özkardeş
Bull Urooncol 2011; 10: 41-46
Full
Text
Read
PDF
Ongoing Studies of the Bladder Tumor Study Group: An Overview
N. Aydın Mungan
İlker Tınay
Bull Urooncol 2014; 13: 67-69
DOI: 10.4274/UOB.01
Full
Text
Read
PDF
Review
Is radical cystectomy the gold standard?
Binhan Kağan Aktaş
Ali Memiş
Bull Urooncol 2013; 12: 1-5
Full
Text
Read
PDF
Bladder cancer epidemiology in the world and in Tukey
Sultan Eser
Raziye Özdemir
Bull Urooncol 2012; 11: 1-9
Full
Text
Read
PDF
The developments in paradigm of prostate cancer in recent years
Sertaç Yazıcı
Halil Kızılöz
Haluk Özen
Bull Urooncol 2014; 13: 1-7
Full
Text
Read
PDF
Prognostic factors in renal cancer and prediction models
Ümit Gül
Özgür Yaycıoğlu
Bull Urooncol 2011; 10: 5-10
Full
Text
Read
PDF
PSA: past, today and tomorrow
Levent Mert Günay
Sertaç Yazıcı
Haluk Özen
Bull Urooncol 2011; 10: 5-10
Full
Text
Read
PDF
Robotic surgery in radical cystectomy
Yakup Kordan
Burhan Coşkun
Bull Urooncol 2013; 12: 6-10
Full
Text
Read
PDF
An update on palliative therapy in advanced prostate cancer
Kaan Özdedeli
Uğur Kuyumcuoğlu
Bull Urooncol 2014; 13: 8-14
Full
Text
Read
PDF
Genetik alteration in bladder carcinoma
Hakan Akça
Onur Tokgün
Bull Urooncol 2012; 11: 10-13
Full
Text
Read
PDF
Geometry of cancer and fractals in bladder cancer
Fehmi Narter
Osman Köse
Bull Urooncol 2013; 12: 11-17
Full
Text
Read
PDF
New approaches to assess the morphology of renal masses
Barbaros Başeskioğlu
Cavit Can
Bull Urooncol 2011; 10: 11-15
Full
Text
Read
PDF
Current analysis of urinary biomarkers for prostate cancer
Faruk Yencilek
Hakan Koyuncu
Bull Urooncol 2011; 10: 11-16
Full
Text
Read
PDF
Positron Emission Tomography/Computed Tomography in Bladder Carcinoma
Recep Bekiş
Emine Acar
Uğur Mungan
Bull Urooncol 2015; 14: 13-17
DOI: 10.4274/uob.236
Full
Text
Read
PDF
The approaches in uncommon malignant tumours of the bladder
Hayrettin Şahin
Bull Urooncol 2012; 11: 14-18
Full
Text
Read
PDF
Prostate cancer, screening and diagnosis according to EAU and AUA 2013 updates and practical considerations
Tünkut Doğanca
Can Öbek
Bull Urooncol 2014; 13: 15-20
Full
Text
Read
PDF
Biopsy of renal mass: The past, present and the future
Tünkut Doğanca
Can Öbek
Bull Urooncol 2011; 10: 16-20
Full
Text
Read
PDF
Can prostate cancer be prevented?
İlkan Yüksel
Mustafa Kaplan
Bull Urooncol 2011; 10: 17-21
Full
Text
Read
PDF
The Relationship between Bladder Cancer and Epigenetic Alterations
Ata Özen
Ali Ülgen
Cavit Can
Bull Urooncol 2017; 16: 17-21
DOI: 10.4274/uob.566
Full
Text
Read
PDF
BCG suşlarının tedavi edici etkinlik farkı var mı?
Hayrettin Şahin
Bull Urooncol 2011; 10: 18-20
Full
Text
Read
PDF
The Risk Stratifications in Non-Muscle Invasive Bladder Cancer: How Much Accurate are the Methods That We Use? A Multi-Directional View
Barış Kuzgunbay
Yıldırım Bayazıt
Bull Urooncol 2015; 14: 18-22
DOI: 10.4274/uob.275
Full
Text
Read
PDF
İdame BCG kime uygulanmalı nasıl uygulanmalı?
Çetin Volkan Öztekin
Veli Erşahin
Bull Urooncol 2011; 10: 21-22
Full
Text
Read
PDF
The role of surgery for high-risk prostate cancer
Oktay Üçer
Talha Müezzinoğlu
Bull Urooncol 2014; 13: 21-24
Full
Text
Read
PDF
Is intravesical BCG treatment necessary and/or sufficient?
Sinan Ekici
Polat Türker
Bull Urooncol 2013; 12: 22-25
Full
Text
Read
PDF
Does inhibition of inflammation help in preventing prostate cancer ?
Ali İhsan Arık
Ahmet Güdeloğlu
Cemil Uygur
Bull Urooncol 2011; 10: 22-26
Full
Text
Read
PDF
The Role of Radiology in Perivesical Invasion of Muscle-Invasive Bladder Cancer
İbrahim İlker Öz
Aydın Mungan
Bull Urooncol 2016; 15: 22-25
DOI: 10.4274/uob.550
Full
Text
Read
PDF
Does the Future of Prostate Cancer Treatment Lie with Apoptotic Inducers?
Dr. Ece Konaç
Dr. Sinan Sözen
Bull Urooncol 2017; 16: 22-27
DOI: 10.4274/uob.606
Full
Text
Read
PDF
BCG komplikasyonları ve başa çıkma
Uğur Yücetaş
Gökhan Toktaş
Bull Urooncol 2011; 10: 23-25
Full
Text
Read
PDF
Radical Cystectomy in Elderly Patients: Predicting Complications and Mortality, Technical Aspects and Postoperative Care
Uğur Kuyumcuoğlu
Kaan Özdedeli
Bull Urooncol 2015; 14: 23-28
DOI: 10.4274/uob.280
Full
Text
Read
PDF
Lympadenectomy in prostate cancer
Murat Koşan
Bull Urooncol 2014; 13: 25-28
Full
Text
Read
PDF
Which Patients Should Undergo Immediate or Deferred Cystectomy in Non-Muscle Invazive Bladder Cancer? Evaluation of...
Şenol Tonyalı
Mustafa Sertaç Yazıcı
Bull Urooncol 2016; 15: 26-30
DOI: 10.4274/uob.536
Full
Text
Read
PDF
The effect of trace elements in prostate cancer
İlker Çelen
Feriye Şenol
Talha Müezzinoğlu
Bull Urooncol 2011; 10: 27-32
Full
Text
Read
PDF
Comparing outcomes of external radiotherapy modalities for prostate cancer
Şefik İğdem
Bull Urooncol 2014; 13: 29-32
Full
Text
Read
PDF
Experimental Bladder Cancer Models for Animals
Murat Koşan
Aydın Mungan
Bull Urooncol 2015; 14: 29-32
DOI: 10.4274/uob.283
Full
Text
Read
PDF
Should all patients with non-muscle invaziv bladder tumor receive postoperative early single dose intravesical chemotherapy?
Sümer Baltacı
Ömer Gülpınar
Bull Urooncol 2012; 11: 30-33
Full
Text
Read
PDF
Limited-standard-extended lymphadenectomy in bladder cancer
Hayrettin Şahin
Bull Urooncol 2013; 12: 31-35
Full
Text
Read
PDF
Synchronous and Metachronous Secondary Tumors of Bladder Cancer Patients
Ayhan Dirim
Hakan Özkardeş
Eray Hasırcı
Bull Urooncol 2016; 15: 31-37
DOI: 10.4274/uob.545
Full
Text
Read
PDF
Has DNA methylation any impact in prostate cancer diagnosis?
Buket Kosova
Rukiye Özel
Çağdaş Aktan
Bull Urooncol 2011; 10: 33-40
Full
Text
Read
PDF
In which fields intermittent androgen deprivation therapy can be used in 2014?
Yasin Ceylan
Bu¨lent Gu¨nlu¨soy
Bull Urooncol 2014; 13: 33-36
Full
Text
Read
PDF
Approach to the complications of intravesical therapy in bladder cancer
Turgay Gülecen
Cüneyd Özkürkçügil
Bull Urooncol 2012; 11: 34-40
Full
Text
Read
PDF
Dev Ta Tümörde TUR nasıl Yapılmalıdır?
Taylan Oksay
Bull Urooncol 2011; 10: 35-37
Full
Text
Read
PDF
Bladder cancer and genetics
Ata Özen
Cavit Can
Bull Urooncol 2013; 12: 36-42
Full
Text
Read
PDF
Surgery in metastatic renal cell carcinoma
Volkan İzol
Bülent Soyupak
Bull Urooncol 2011; 10: 36-40
Full
Text
Read
PDF
TUR'a bağlı mesane perforasyonu: tedavi ve izlem
Kürsad Zengin
Sinan Başay
Bull Urooncol 2011; 10: 38-40
Full
Text
Read
PDF
Screening for Bladder Cancer: Reliability and Limitations
Kamil Fehmi Narter
Cahit Şahin
Bull Urooncol 2015; 14: 38-45
DOI: 10.4274/uob.238
Full
Text
Read
PDF
Recent advancements in the targeted therapy of metastatic kidney cancer
Sertaç Yazıcı
Halil Kızılöz
Haluk Özen
Bull Urooncol 2011; 10: 41-51
Full
Text
Read
PDF
Active Surveillance: Treatment Modality that Expect Attention for Localized Prostate Cancer
Tayyar Alp Özkan
Özdal Dillioğlugil
Bull Urooncol 2014; 13: 41-45
Full
Text
Read
PDF
Nursing care following radical cystectomy and urinary diversion
Cemile Ulubay Akkaya
Bull Urooncol 2013; 12: 43-45
Full
Text
Read
PDF
Is it possible to predict BCG effectivity in the treatment of superficial bladder cancer? Are there any markers?
Polat Türker
Sinan Ekici
Bull Urooncol 2012; 11: 46-51
Full
Text
Read
PDF
History of Urologic Oncology in Turkey: Bladder Cancers
Yaşar Bedük
Bull Urooncol 2015; 14: 46-49
DOI: 10.4274/uob.295
Full
Text
Read
PDF
A critical analysis of surgical curative treatments options in localised prostate cancer: open, laparoscopic, and robotassisted radical prostatectomy
Ender Özden
Yakup Bostancı
Yarkın Kamil Yakupoğlu
Bull Urooncol 2011; 10: 47-50
Full
Text
Read
PDF
Genişletilmiş lenfadenektomi standart bir tedavi olmalı mı?
Ömer Gökhan Doluoğlu
Mehmet Karabakan
Bull Urooncol 2011; 10: 48-50
Full
Text
Read
PDF
Experimental animal models for bladder cancer
Şevket Tolga Tombul
Talha Müezzinoğlu
Bull Urooncol 2013; 12: 50-53
Full
Text
Read
PDF
The role of 5α-reductase inhibitors on prevention and hormonal treatment of prostate cancer
Bülent Öztürk
Tufan Çiçek
Bull Urooncol 2014; 13: 50-53
Full
Text
Read
PDF
Non-Muscle Invasive Bladder Cancer: Diagnosis and Treatment of Highest-Risk Subgroup
Yılören Tanıdır
İlker Tınay
Bull Urooncol 2015; 14: 50-54
DOI: 10.4274/uob.298
Full
Text
Read
PDF
Algorithmic approach to rising PSA after curative prostate cancer treatment
Levent Mert Günay
Şevket Tolga Tombul
Bülent Akdoğan
Bull Urooncol 2011; 10: 51-55
Full
Text
Read
PDF
Açık, laparoskopik ve robotik sistektomi: avantaj ve dezavantajları
Bülent Altunoluk
Bull Urooncol 2011; 10: 51-54
Full
Text
Read
PDF
The Role of Imaging in Testicular Cancer Diagnosis, Staging and Follow-up
Nuray Voyvoda
Bekir Voyvoda
Özden Çamurdan
Bull Urooncol 2017; 16: 51-56
DOI: 10.4274/uob.694
Full
Text
Read
PDF
Radiological methods that aid in the diagnosis of bladder cancer
Fatih Kantarcı
Deniz Çebi Olgun
Atilla Süleyman Dikici
Bull Urooncol 2013; 12: 54-57
Full
Text
Read
PDF
The influence of age on localized prostate cancer: Surgical result of patients over 70 years
Erdal Benli
Ali Ayyıldız
Bull Urooncol 2014; 13: 54-57
Full
Text
Read
PDF
Can Bladder be Preserved with TURB + Chemotherapy instead of Radical Surgery (Can we Preserve the Bladder from Cancer)
Cavit Can
Bull Urooncol 2012; 11: 55-57
Full
Text
Read
PDF
Quality of Life after Radical Cystectomy and Diversion
Gökhan Toktaş
Emre Karabay
Bull Urooncol 2015; 14: 55-60
DOI: 10.4274/uob.299
Full
Text
Read
PDF
Could focal therapy in prostate cancer replace standard therapy in the future?
Saadettin Y. Eskiçorapçı
Cihan Toktaş
Bull Urooncol 2011; 10: 56-62
Full
Text
Read
PDF
Risk Adaptive Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer
Elif Atağ
Aziz Karaoğlu
Ömer Küçük
Bull Urooncol 2017; 16: 57-62
DOI: 10.4274/uob.763
Full
Text
Read
PDF
Neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer
Aziz Karaoğlu
Utku Oflazoğlu
Necla Demir
Bull Urooncol 2013; 12: 58-63
Full
Text
Read
PDF
Outstanding variations in the treatment of prostate cancer bone metastases
İbrahim Cüreklibatır
Bull Urooncol 2014; 13: 58-62
Full
Text
Read
PDF
Role of Nanoparticles in the Treatment of Noninvasive Bladder Cancer
Erem Bilensoy
Nazlı Erdoğar
Aydın N. Mungan
Bull Urooncol 2015; 14: 61-66
DOI: 10.4274/uob.246
Full
Text
Read
PDF
Neoadjuvant and adjuvant treatment modalities for prostate cancer
Erkan Erkan
Gökhan Toktaş
Bull Urooncol 2011; 10: 63-69
Full
Text
Read
PDF
How affected Active Surveillance the quality of life in low-risk localized prostate cancer?
İlker Çelen
Sinharib Çitgez
Talha Müezzinoğlu
Bull Urooncol 2014; 13: 63-66
Full
Text
Read
PDF
The importance of cellular androgenic hormonal mechanisms in treatment and progression of prostate cancer
Bertrand Tombal
Bull Urooncol 2013; 12: 65-70
Full
Text
Read
PDF
A New Era in Metastatic Prostate Cancer: “The Combination of Chemotherapy and Hormonal Treatment as Initial Treatment”
İlker Tinay
Levent Türkeri
Bull Urooncol 2016; 15: 65-68
DOI: 10.4274/uob.434
Full
Text
Read
PDF
Targeted Therapies in Metastatic Bladder Cancer: Has It Been Approved as a Treatment Option Nowadays?
Nil Molinas Mandel
Bull Urooncol 2015; 14: 67-70
DOI: 10.4274/uob.2015.14.001
Full
Text
Read
PDF
Management of post-chemotherapy residual masses in testicular tumor and surgical tecnique
Ferhat Ateş
Ömer Yılmaz
Kadir Vehbi Baykal
Bull Urooncol 2011; 10: 68-74
Full
Text
Read
PDF
Sentinel Lymph Node Biopsy in Lymphadenectomy for Prostate Cancer
Cenk Acar
Henk van der Poel
Bull Urooncol 2016; 15: 69-75
DOI: 10.4274/uob.625
Full
Text
Read
PDF
What is the evidence-based ideal treatment of clinical locally advanced (cT3) prostate cancer?
Asıf Yıldırım
Erem Kaan Başok
Bull Urooncol 2011; 10: 70-75
Full
Text
Read
PDF
Is prostate cancer be screened according to Turkey data?
Rahmi Gökhan Ekin
Ferruh Zorlu
Bull Urooncol 2013; 12: 71-75
Full
Text
Read
PDF
Surgical Approaches in Patients with Metastatic Bladder Cancer: Metastasectomy and Palliative Cystectomy
Utku Lokman
Özgür Uğurlu
Bull Urooncol 2014; 13: 75-78
DOI: 10.4274/UOB.03
Full
Text
Read
PDF
Active surveillance in low risk prostate cancer
Ozan Bozkurt
Ömer Demir
Bull Urooncol 2013; 12: 76-79
Full
Text
Read
PDF
Hormonal treatment of metastatic prostate cancer: Today and future
Hasan Soydan
Kadir Baykal
Bull Urooncol 2011; 10: 76-81
Full
Text
Read
PDF
Magnetic Resonance - Transrectal Ultrasound Fusion Guided Prostate Biopsy
Ömer Burak Argun
Can Öbek
Ali Rıza Kural
Bull Urooncol 2016; 15: 76-79
DOI: 10.4274/uob.635
Full
Text
Read
PDF
Approaches to Upper Urinary Tract Recurrences Following Radical Cystectomy
Mehmet İlker Gökçe
Sümer Baltacı
Bull Urooncol 2014; 13: 79-83
DOI: 10.4274/UOB.04
Full
Text
Read
PDF
Treatment options in low-intermediate risk prostate cancer
Saadettin Yılmaz Eskiçorapçı
Deniz Bolat
Bull Urooncol 2013; 12: 80-85
Full
Text
Read
PDF
Robotic assisted laparoscopic surgery for the treatment of kidney cancer:current status in 2011
Cihan Toktaş
Saadettin Eskiçorapçı
Bull Urooncol 2011; 10: 82-85
Full
Text
Read
PDF
Immunotherapy in prostate cancer
Murat Lekili
Bull Urooncol 2011; 10: 82-84
Full
Text
Read
PDF
Comparison of the Clinical and Pathologic Staging in Patients Undergoing Radical Cystectomy, the Factors Associated with Upstaging and its Effect on Outcome
Polat Türker
Bull Urooncol 2014; 13: 84-87
DOI: 10.4274/UOB.05
Full
Text
Read
PDF
Nomograms for prostate cancer: which and when to use
Saadettin Eskiçorapçı
Deniz Bolat
Bull Urooncol 2012; 11: 85-91
Full
Text
Read
PDF
Are there any treatment option for metastatic prostate cancer refractory to docetaksel?
Yaşar Bedük
Bull Urooncol 2011; 10: 85-89
Full
Text
Read
PDF
Radiotherapy in low and intermediate-risk prostate cancer
Deniz Yalman
Bull Urooncol 2013; 12: 86-91
Full
Text
Read
PDF
Transurethral Resection of Bladder Cancer (TUR-B) for Non-Muscle Invasive Bladder Cancer: How to Reach Excellence?
Mehmet İlker Gökçe
Yaşar Bedük
Bull Urooncol 2014; 13: 88-92
DOI: 10.4274/UOB.06
Full
Text
Read
PDF
Recommendations of Diet and Lifestyle in Prostate Cancer Patients
Serdar Çelik
Bull Urooncol 2015; 14: 88-93
DOI: 10.4274/uob.307
Full
Text
Read
PDF
What is the best cutoff value of PSA in detection of prostate cancer
Hakan Gemalmaz
Bull Urooncol 2012; 11: 92-95
Full
Text
Read
PDF
Relationship Between Human Papilloma Virus and Bladder Cancer
Osman İnci
Ebru Taştekin
Hakan Akdere
Bull Urooncol 2017; 16: 92-94
DOI: 10.4274/uob.556
Full
Text
Read
PDF
Which Treatment Should We Prefer for High-Risk Nonmuscle Invasive Bladder Cancer? Early Cystectomy or Bladder Sparing?
Ali Furkan Batur
Sinan Sözen
Bull Urooncol 2014; 13: 93-98
DOI: 10.4274/UOB.07
Full
Text
Read
PDF
What is the Approach to Negative Prostate Biopsies?
Bora İrer
Güven Aslan
Bull Urooncol 2015; 14: 94-96
DOI: 10.4274/uob.310
Full
Text
Read
PDF
What are the New Developments in Urinary, Serum and Tissue Biomarkers in Prostate Cancer?
Hayrettin Şahin
Mehmet Çetinkaya
Hasan Deliktaş
Bull Urooncol 2017; 16: 95-100
DOI: 10.4274/uob.620
Full
Text
Read
PDF
NON-PSA biomarkers for prostate cancer
Yarkın Kamil Yakupoğlu
Yakup Bostancı
Ender Özden
Bull Urooncol 2012; 11: 96-102
Full
Text
Read
PDF
Surgical treatment and/or radiotherapy in high risk prostate cancer
Fatih Bıçaklıoğlu
Cenk Acar
Sinan Sözen
Bull Urooncol 2013; 12: 97-101
Full
Text
Read
PDF
Intermittent Versus Continuous Androgen Deprivation in Patients with Metastatic Prostate Cancer: Review
Mehmet Yıldızhan
Mehmet Dündar
Mehmet Şirin Ertek
Bull Urooncol 2015; 14: 97-101
DOI: 10.4274/uob.315
Full
Text
Read
PDF
Evaluation of the Current Situation Tissue and Serum Biomarkers in Prostate Cancer
Enis Kervancıoğlu
Murat Koşan
Bull Urooncol 2015; 14: 102-107
DOI: 10.4274/uob.320
Full
Text
Read
PDF
The Approach to High Risk Bladder Cancers in The Absence of Bacillus Calmette Guérin: What should Be the Treatment and Follow Up?
Polat Türker
Levent Türkeri
Bull Urooncol 2014; 13: 103-108
DOI: 10.4274/UOB.09
Full
Text
Read
PDF
Repeat prostate biopsy: who, when, how?
Hayrettin Şahin
Bull Urooncol 2012; 11: 103-107
Full
Text
Read
PDF
New treatment options for the castration resistant prostate cancer targeting the androgen synthesis and androgen receptor
Yavuz Selim Süral
Çağ Çal
Bull Urooncol 2013; 12: 106-110
Full
Text
Read
PDF
Controversies in Radical Cystectomy: Meta-Analysis and Systemic Comparison of Open Surgery with Laparoscopic and Robotic Surgery
Mehmet Kaynar
Serdar Göktaş
Bull Urooncol 2016; 15: 107-112
DOI: 10.4274/uob.542
Full
Text
Read
PDF
Focal Therapy for Prostate Cancer: Current Status of HIFU
Tayyar Alp Özkan
Saadettin Eskiçorapçı
Bull Urooncol 2015; 14: 108-112
DOI: 10.4274/uob.321
Full
Text
Read
PDF
Does Urinary Cytology Find the Value in the Detection and Follow-up of Urinary Bladder Cancer?
Kutsal Yörükoğlu
Bull Urooncol 2014; 13: 109-112
DOI: 10.4274/UOB.10
Full
Text
Read
PDF
New treatment options in castration resistant prostate cancer: enzalutamide and abiraterone acetate
Bülent Akdoğan
Bull Urooncol 2013; 12: 111-114
Full
Text
Read
PDF
Hexyl Aminolevulinate-Guided Fluorescence Cystoscopy in the Diagnosis of Patients with Non-Muscle Invasive Bladder Cancer: A Review Based on Meta-Analysis
Emre Tüzel
Bull Urooncol 2014; 13: 113-118
DOI: 10.4274/UOB.11
Full
Text
Read
PDF
Radical Prostatectomy and Lymphadenectomy in the High-Risk Prostate Cancer: Surgical Technique, Functional and Oncologic Outcomes
Hayrettin Şahin
Hasan Deliktaş
Bull Urooncol 2015; 14: 113-119
DOI: 10.4274/uob.324
Full
Text
Read
PDF
Active surveillance for localized prostate cancer
İlker Tınay
Levent Türkeri
Bull Urooncol 2012; 11: 114-118
Full
Text
Read
PDF
New treatment options for the castration resistant prostate cancer: Cabazitaxel and Spileucel-T
Gürbüz Görümlü
Erdem Göker
Bull Urooncol 2013; 12: 115-117
Full
Text
Read
PDF
New treatment options in castration resistant prostate cancer: denosumab, alpharadin
Hakan Gemalmaz
Bull Urooncol 2013; 12: 118-122
Full
Text
Read
PDF
Bladder Perforation During TUR of Non Muscle Invasive Bladder Tumours: Early and Late Management
Deniz Arslan
Bull Urooncol 2014; 13: 119-121
DOI: 10.4274/UOB.12
Full
Text
Read
PDF
Surgical technique of nerve sparing radical prostatectomy and periprostatic field anatomy
Ali Cansu Bozacı
Bülent Akdoğan
Haluk Özen
Bull Urooncol 2012; 11: 119-123
Full
Text
Read
PDF
Treatment Approaches for Nonmetastatic Castration-Resistant Prostate Cancer
Mehmet Yıldızhan
Hakan Gemalmaz
Mehmet Şirin Ertek
Bull Urooncol 2015; 14: 120-127
DOI: 10.4274/uob.328
Full
Text
Read
PDF
Relationship between active surveillance / watchfull waiting and quality of life in localised prostate cancer
İlker Çelen
Yasin Ceylan
Bull Urooncol 2013; 12: 123-126
Full
Text
Read
PDF
Current surgical approaches in local invasive prostate cancer: urologist approach
Zafer Kozacıoğlu
Bülent Günlüsoy
Bull Urooncol 2012; 11: 124-128
Full
Text
Read
PDF
How shoud PSA repalse (rising PSA) be managed after radical prostatectomy? How should treatment algorithms be shaped?
İlker Çelen
Murat Lekili
Bull Urooncol 2013; 12: 127-131
Full
Text
Read
PDF
The Status of Testicular Self-Examination in the Early Diagnosis of TesticularCancer: Conjuncture in the World and in Turkey
Barış Kuzgunbay
Bull Urooncol 2014; 13: 127-129
DOI: 10.4274/uob.71
Full
Text
Read
PDF
Active Surveillance in Prostate Cancer
Volkan İzol
Nebil Akdoğan
Bull Urooncol 2017; 16: 127-132
DOI: 10.4274/uob.820
Full
Text
Read
PDF
Prostate Biopsy 2014: TRUS, MRI/TRUS Fusion? Transrectal? Transperineal?
Kaan Çömez
Ozan Bozkurt
Mehmet Uğur Mungan
Bull Urooncol 2015; 14: 128-135
DOI: 10.4274/uob.329
Full
Text
Read
PDF
Current treatment approaches in locally advanced prostate cancer: a radiation oncologist perspective
Ömür Karakoyun Çelik
Bull Urooncol 2012; 11: 129-133
Full
Text
Read
PDF
Radical prostatectomy indications and outcomes in the high-risk localised prostate cancer
Hayrettin Şahin
Hasan Deliktaş
Bull Urooncol 2013; 12: 132-136
Full
Text
Read
PDF
Management of recurrences after radiation therapy used for curative intent in prostate cancer
Yılören Tanıdır
Levent Türkeri
Bull Urooncol 2012; 11: 134-141
Full
Text
Read
PDF
Risk Factors and Etiology in Renal Cell Carcinoma
Ümit Gül
Bull Urooncol 2014; 13: 135-138
DOI: 10.4274/uob.78
Full
Text
Read
PDF
Multiparametric MR in Prostate Cancer: General Practical Application Advices
Seçil Mustafa
Basara Işıl
Altay Canan
Bull Urooncol 2015; 14: 136-143
DOI: 10.4274/uob.330
Full
Text
Read
PDF
Salvage radical prostatectomy for locally recurrent prostate cancer following primary radiotherapy
Ali Cansu Bozacı
Sertaç Yazıcı
Bull Urooncol 2013; 12: 137-141
Full
Text
Read
PDF
Adjuvant and Neoadjuvant Targeted Therapies in Locally Advanced Renal Cell Carcinoma
Ozan Bozkurt
Ömer Demir
Bull Urooncol 2014; 13: 139-145
DOI: 10.4274/uob.82
Full
Text
Read
PDF
AUA/ASTRO 2013 Guidelines for Adjuvant and Salvage Radiation Therapy After Prostatectomy: What are the Yields and the Changes?
Deniz Yalman
Bull Urooncol 2015; 14: 144-149
DOI: 10.4274/uob.339
Full
Text
Read
PDF
An Update on Cancers of Penis
Ali Furkan Batur
Bull Urooncol 2014; 13: 146-152
DOI: 10.4274/uob.87
Full
Text
Read
PDF
The role of surgery in renal cell carcinoma metastasis
Levent Mert Günay
Mehmet Cemil Uygur
Bull Urooncol 2013; 12: 147-150
Full
Text
Read
PDF
Prostate cancer in the era of robotic surgery
Çag Çal
Bull Urooncol 2012; 11: 150-155
Full
Text
Read
PDF
‘Nanotechnology Applications’ in the Treatment of Prostate Cancer
Ali Furkan Batur
Kerem Gencer Kutman
Mustafa Suat Bolat
Bull Urooncol 2015; 14: 150-155
DOI: 10.4274/uob.375
Full
Text
Read
PDF
Society of Urooncology nomogram for kidney cancer – the user's manual
Özgür Yaycıoğlu
Bull Urooncol 2013; 12: 151-154
Full
Text
Read
PDF
Risk Factors for Urothelial Cancers
Ümit Gül
Barış Kuzgunbay
Bull Urooncol 2016; 15: 154-158
DOI: 10.4274/uob.554
Full
Text
Read
PDF
Genetic alterations in kidney cancer
Onur Tokgün
Hakan Akça
Bull Urooncol 2013; 12: 155-162
Full
Text
Read
PDF
Immunotherapy for the treatment of castration resistant prostate cancer: sipuleucel-T
Güven Aslan
Bull Urooncol 2012; 11: 156-158
Full
Text
Read
PDF
Active Surveillance-Factors Affecting the Treatment Decision: 3M: “Marker”, “Mapping”, “MRI”
Ender Özden
Mehmet Necmettin Mercimek
Bull Urooncol 2015; 14: 156-160
DOI: 10.4274/uob.379
Full
Text
Read
PDF
New treatment stragies in metastatic castration resistant prostate cancer: Re-Docetaxel, Abiraterone asetate, Cabazitaxel, MDV 3100
Sıtkı Ün
Ferruh Zorlu
Bull Urooncol 2012; 11: 159-163
Full
Text
Read
PDF
Information about Prostate Cancer for Urologist: Ga-68 Prostate Specific Membrane Antigen Positron Emission Tomography/Computed Tomography Scintigraphy
Levent Kabasakal
Bull Urooncol 2016; 15: 159-162
DOI: 10.4274/uob.616
Full
Text
Read
PDF
Rising Psa After Radical Prostatectomy: Radiotherapy in High Risk Group: Early? Late?
Gül Alço
Sefik İğdem
Bull Urooncol 2015; 14: 161-164
DOI: 10.4274/uob.387
Full
Text
Read
PDF
Active Surveillance in Prostate Cancer: Can We Expand the Indications?
Hacı Murat Akgül
Asgar Garayev
İlker Tinay
Bull Urooncol 2016; 15: 163-166
DOI: 10.4274/uob.619
Full
Text
Read
PDF
Update in the management of skeletal related events for metastatic prostate cancer: Denosumab, Alfaradin
Serdar Çelik
Uğur Mungan
Bull Urooncol 2012; 11: 164-167
Full
Text
Read
PDF
The significance of tertiary Gleason pattern in prostate cancer
H. Hüseyin Tavukçu
Polat Türker
Bull Urooncol 2012; 11: 168-172
Full
Text
Read
PDF
Sperm preservation in patients with testicular cancer
Mehmet Kazım Asutay
İlker Tınay
Cem Akbal
Bull Urooncol 2013; 12: 169-172
Full
Text
Read
PDF
Postchemotherapy Retroperitoneal Lymph Node Dissection
Burak Çıtamak
Bülent Akdoğan
Mesut Altan
Haluk Özen
Bull Urooncol 2014; 13: 169-175
DOI: 10.4274/uob.138
Full
Text
Read
PDF
Nursing interventions in patients receiving Taxan Chemotherapy
Yeter Kırdal
Bull Urooncol 2012; 11: 173-177
Full
Text
Read
PDF
Infertility and Sperm Cryopreservation in Patients with Testicular Cancer
Mustafa Emre Bakırcıoğlu
Bülent Alıcı
Bull Urooncol 2014; 13: 176-181
DOI: 10.4274/uob.146
Full
Text
Read
PDF
F-18 fluorodeoxyglucose positron emission tomography in testicular cancer
Gül Gümüser
Feray Aras
Elvan Sayit Bilgin
Bull Urooncol 2012; 11: 193-195
Full
Text
Read
PDF
Follow-up principles after curative treatment in renal cancer
Ercan Kazan
Hakan Gemalmaz
Bull Urooncol 2013; 12: 194-200
Full
Text
Read
PDF
Chemotherapy related adverse events in patients with testicular cancer
Özgür Tanrıverdi
Bülent Karabulut
Bull Urooncol 2012; 11: 196-200
Full
Text
Read
PDF
Liquid Biopsy: Circulating Tumor Cells and its Impact on Follow-up/Treatment of Prostate Cancer Patients
İbrahim Kulaç
Bull Urooncol 2014; 13: 196-200
DOI: 10.4274/uob.159
Full
Text
Read
PDF
Renal cell cancer pathology and molecular biology
Burçin Tuna
Bull Urooncol 2013; 12: 201-204
Full
Text
Read
PDF
Nephron Sparing Surgery for Localized Renal Tumors - Quality of Life at a Glance
Yilören Tanıdır
Ferhad Talibzade
Muhammed Sulukaya
Bull Urooncol 2014; 13: 201-205
DOI: 10.4274/uob.160
Full
Text
Read
PDF
Testicular cancers: developments in radiotherapy
Şefik İğdem
Gül Alço
Bull Urooncol 2013; 12: 210-213
Full
Text
Read
PDF
Targeted Therapies in Advanced Renal Cell Cancer
Sinan Karaaslan
Bull Urooncol 2015; 14: 210-213
DOI: 10.4274/uob.396
Full
Text
Read
PDF
Should the treatment approach be different for incidental renal tumors? Turkey databases
Emre Huri
Bull Urooncol 2012; 11: 216-220
Full
Text
Read
PDF
Molecular Biology in Diagnosis and Treatment of Prostate Cancer
Ece Konaç
Sinan Sözen
Bull Urooncol 2014; 13: 228-235
DOI: 10.4274/uob.194
Full
Text
Read
PDF
Hemostatic agents in open partial nephrectomy
Kemal Ener
Emrah Okulu
Önder Kayıgil
Bull Urooncol 2012; 11: 230-233
Full
Text
Read
PDF
Approach to renal cell carcinoma with vena cava and adrenal involvement and interpretation of data of Turkey by 2012
Mehmet İlker Gökçe
Bull Urooncol 2012; 11: 234-239
Full
Text
Read
PDF
Neoadjuvant targeted therapy in renal cell carcinoma
Sertaç Yazıcı
Halil Kızılöz
Haluk Özen
Bull Urooncol 2012; 11: 240-245
Full
Text
Read
PDF
Current Situation in the Use of 5-Alpha Reductase Inhibitors for Prostatic Diseases
Murat Koşan
Bull Urooncol 2014; 13: 244-246
DOI: 10.4274/uob.212
Full
Text
Read
PDF
Diagnostic and Prognostic Molecular Features of Urothelial Bladder Cancer and New Treatment Approaches
Zafer Küçükodacı
Kutsal Yörükoğlu
Bull Urooncol 2015; 14: 258-270
DOI: 10.4274/uob.366
Full
Text
Read
PDF
The Effects of Hormonal Therapy on Quality of Life in Prostate Cancer
Yusuf Şenoğlu
Kamil Çam
Bull Urooncol 2015; 14: 317-320
DOI: 10.4274/uob.463
Full
Text
Read
PDF
Quality of Life of Patients with Advanced/Metastatic Renal Cell Carcinoma During the Treatment Period with Targeted Drugs
Sinharib Çitgez
Bull Urooncol 2015; 14: 321-323
DOI: 10.4274/uob.460
Full
Text
Read
PDF
Quality Of Life
How should we manage infertility in testicular cancer patients?
Hakan Özveri
Enis Rauf Coşkuner
Bull Urooncol 2011; 10: 95-101
Full
Text
Read
PDF
What is the status of spouses in prostate cancer? Is their quality of life affected?
Hakan Gemalmaz
Bull Urooncol 2011; 10: 103-107
Full
Text
Read
PDF
Management of post radical retropubic prostatectomy incontinence
Adnan Şimşir
Gökhan Temeltaş
Bull Urooncol 2011; 10: 108-111
Full
Text
Read
PDF
Can we prevent erectile dysfunction following radical prostatectomy? What are the medical and surgical alternatives?
Cem Akbal
Ferruh Şimsek
Bull Urooncol 2011; 10: 112-116
Full
Text
Read
PDF
The comparison of the treatment alternatives on quality of life in testicular cancers
Sinharib Çitgez
Çetin Demirdağ
Kamil Çam
Bull Urooncol 2013; 12: 271-275
Full
Text
Read
PDF
Bph
Statin's role on protection from the benign prostatic hyperplasia and prostate cancer
Eray Hasırcı
A. İbrahim Oğuzülgen
Bull Urooncol 2012; 11: 270-274
Full
Text
Read
PDF
Pathology
Prostate cancer: New developments in pathogenesis and prognostic repercussions
Bora Gürel
Bull Urooncol 2013; 12: 279-284
Full
Text
Read
PDF
1
2
3
4
5
»
Advanced Search
About Journal
Forms
Useful Links
Subscribe
×
×
Subscribe
Full Name
E-mail